Concepts (111)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Breast Neoplasms | 2 | 2024 | 144 | 1.500 |
Why?
|
| Wound Healing | 5 | 2021 | 13 | 1.430 |
Why?
|
| Mastectomy | 2 | 2024 | 4 | 1.110 |
Why?
|
| Mammaplasty | 1 | 2024 | 5 | 0.900 |
Why?
|
| Healthcare Disparities | 1 | 2024 | 69 | 0.850 |
Why?
|
| Urinary Retention | 1 | 2023 | 2 | 0.840 |
Why?
|
| Body Fluids | 1 | 2023 | 7 | 0.830 |
Why?
|
| Skin | 3 | 2018 | 7 | 0.630 |
Why?
|
| beta Catenin | 1 | 2018 | 8 | 0.580 |
Why?
|
| Wnt Signaling Pathway | 1 | 2018 | 6 | 0.580 |
Why?
|
| Wnt Proteins | 3 | 2018 | 10 | 0.550 |
Why?
|
| Skin Transplantation | 2 | 2018 | 3 | 0.540 |
Why?
|
| Fibroblasts | 2 | 2018 | 20 | 0.470 |
Why?
|
| Chorioallantoic Membrane | 1 | 2012 | 1 | 0.390 |
Why?
|
| Skin Physiological Phenomena | 1 | 2012 | 2 | 0.390 |
Why?
|
| Fetal Tissue Transplantation | 1 | 2012 | 2 | 0.390 |
Why?
|
| Models, Animal | 1 | 2012 | 17 | 0.390 |
Why?
|
| Animals | 10 | 2018 | 1369 | 0.360 |
Why?
|
| Hyaluronic Acid | 1 | 2010 | 9 | 0.330 |
Why?
|
| Fetus | 1 | 2010 | 114 | 0.320 |
Why?
|
| Female | 4 | 2024 | 2964 | 0.290 |
Why?
|
| Humans | 5 | 2024 | 4931 | 0.260 |
Why?
|
| Wnt3A Protein | 3 | 2018 | 3 | 0.250 |
Why?
|
| Mice, Inbred Strains | 3 | 2018 | 20 | 0.250 |
Why?
|
| Mice | 7 | 2012 | 555 | 0.250 |
Why?
|
| Cicatrix | 2 | 2018 | 2 | 0.240 |
Why?
|
| Socioeconomic Factors | 1 | 2024 | 146 | 0.220 |
Why?
|
| Catheters | 1 | 2023 | 6 | 0.210 |
Why?
|
| Cells, Cultured | 4 | 2018 | 164 | 0.210 |
Why?
|
| Health Services Accessibility | 1 | 2024 | 124 | 0.200 |
Why?
|
| Health Literacy | 1 | 2022 | 35 | 0.190 |
Why?
|
| Osteogenesis | 3 | 2010 | 4 | 0.190 |
Why?
|
| Sarcoma | 1 | 2021 | 1 | 0.180 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2021 | 1 | 0.180 |
Why?
|
| Cell Proliferation | 3 | 2018 | 101 | 0.170 |
Why?
|
| Cranial Sutures | 2 | 2010 | 2 | 0.170 |
Why?
|
| Rotator Cuff Injuries | 1 | 2018 | 1 | 0.150 |
Why?
|
| Surgical Flaps | 1 | 2018 | 4 | 0.150 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2018 | 1 | 0.150 |
Why?
|
| Re-Epithelialization | 1 | 2018 | 1 | 0.150 |
Why?
|
| Injections, Subcutaneous | 1 | 2018 | 12 | 0.150 |
Why?
|
| Recombinant Proteins | 1 | 2018 | 36 | 0.150 |
Why?
|
| Hypoxia | 1 | 2018 | 30 | 0.140 |
Why?
|
| Transforming Growth Factor beta | 1 | 2018 | 45 | 0.140 |
Why?
|
| Mice, Inbred BALB C | 2 | 2012 | 34 | 0.120 |
Why?
|
| Signal Transduction | 3 | 2010 | 162 | 0.110 |
Why?
|
| Prions | 1 | 2013 | 1 | 0.110 |
Why?
|
| Copper | 1 | 2013 | 2 | 0.110 |
Why?
|
| Astrocytes | 1 | 2013 | 8 | 0.110 |
Why?
|
| Peptides | 1 | 2013 | 14 | 0.110 |
Why?
|
| Mesoderm | 2 | 2010 | 9 | 0.100 |
Why?
|
| Stromal Cells | 2 | 2010 | 5 | 0.100 |
Why?
|
| Bromodeoxyuridine | 2 | 2010 | 2 | 0.100 |
Why?
|
| Wnt3 Protein | 2 | 2010 | 4 | 0.100 |
Why?
|
| Chick Embryo | 1 | 2012 | 2 | 0.100 |
Why?
|
| Lasers, Solid-State | 1 | 2012 | 2 | 0.100 |
Why?
|
| Nanoparticles | 1 | 2011 | 5 | 0.090 |
Why?
|
| Calcium | 1 | 2011 | 63 | 0.090 |
Why?
|
| Osteoblasts | 1 | 2010 | 2 | 0.090 |
Why?
|
| Hedgehog Proteins | 1 | 2010 | 5 | 0.090 |
Why?
|
| Adipocytes | 1 | 2010 | 22 | 0.090 |
Why?
|
| Craniosynostoses | 1 | 2010 | 1 | 0.090 |
Why?
|
| Retinoids | 1 | 2010 | 2 | 0.080 |
Why?
|
| Tretinoin | 1 | 2010 | 11 | 0.080 |
Why?
|
| Glucuronosyltransferase | 1 | 2010 | 1 | 0.080 |
Why?
|
| Wnt4 Protein | 1 | 2010 | 2 | 0.080 |
Why?
|
| Histone Deacetylases | 1 | 2009 | 1 | 0.080 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2009 | 1 | 0.080 |
Why?
|
| Hyaluronan Synthases | 1 | 2010 | 4 | 0.080 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2010 | 16 | 0.080 |
Why?
|
| Oxygen | 1 | 2009 | 33 | 0.080 |
Why?
|
| Estrogen Receptor alpha | 1 | 2009 | 10 | 0.080 |
Why?
|
| Estrogens | 1 | 2009 | 24 | 0.080 |
Why?
|
| Adipose Tissue | 1 | 2009 | 56 | 0.080 |
Why?
|
| Male | 3 | 2022 | 2620 | 0.060 |
Why?
|
| Feminization | 1 | 2022 | 1 | 0.050 |
Why?
|
| Comprehension | 1 | 2022 | 7 | 0.050 |
Why?
|
| Internet | 1 | 2022 | 22 | 0.050 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2021 | 4 | 0.050 |
Why?
|
| Postoperative Complications | 1 | 2021 | 82 | 0.040 |
Why?
|
| Adipogenesis | 2 | 2010 | 10 | 0.040 |
Why?
|
| Alkaline Phosphatase | 2 | 2010 | 30 | 0.040 |
Why?
|
| Cell Differentiation | 2 | 2010 | 64 | 0.040 |
Why?
|
| Gene Expression Regulation | 2 | 2009 | 83 | 0.040 |
Why?
|
| Retrospective Studies | 1 | 2021 | 513 | 0.040 |
Why?
|
| Risk Factors | 1 | 2021 | 593 | 0.040 |
Why?
|
| Acromion | 1 | 2018 | 1 | 0.040 |
Why?
|
| Suture Anchors | 1 | 2018 | 1 | 0.040 |
Why?
|
| Transplantation, Autologous | 1 | 2018 | 5 | 0.040 |
Why?
|
| Cadaver | 1 | 2018 | 9 | 0.040 |
Why?
|
| Adult | 1 | 2021 | 1402 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2018 | 402 | 0.030 |
Why?
|
| Protein Structure, Secondary | 1 | 2013 | 2 | 0.030 |
Why?
|
| Protein Binding | 1 | 2013 | 21 | 0.030 |
Why?
|
| Aged | 1 | 2018 | 1188 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 2013 | 38 | 0.030 |
Why?
|
| Middle Aged | 1 | 2018 | 1544 | 0.030 |
Why?
|
| Rats | 1 | 2013 | 373 | 0.030 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2010 | 6 | 0.020 |
Why?
|
| Gene Expression | 1 | 2010 | 55 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2010 | 76 | 0.020 |
Why?
|
| Butyrates | 1 | 2009 | 1 | 0.020 |
Why?
|
| Valproic Acid | 1 | 2009 | 4 | 0.020 |
Why?
|
| Tibia | 1 | 2009 | 2 | 0.020 |
Why?
|
| Estrogen Antagonists | 1 | 2009 | 5 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 72 | 0.020 |
Why?
|
| Estradiol | 1 | 2009 | 47 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2009 | 112 | 0.020 |
Why?
|
| Liposomes | 1 | 2008 | 5 | 0.020 |
Why?
|
| Membrane Lipids | 1 | 2008 | 3 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2008 | 11 | 0.020 |
Why?
|